xromi-us.com

XROMI® (hydroxyurea) Oral solution | U.S. Website

XROMI® is indicated to reduce the frequency of painful crises and reduce the need for blood transfusions in pediatric patients aged 6 months of age to less than 2 years, with sickle cell anemia with recurrent moderate to severe painful crises.

Last seen: January 18th at 3:41pm — Visit site